James P. Boylan - 08 Mar 2024 Form 4 Insider Report for Compass Therapeutics, Inc. (CMPX)

Role: Director
Signature: /s/ Neil Lerner, as attorney-in-fact
Issuer symbol: CMPX
Transactions as of: 08 Mar 2024
Net transactions value: $0
Form type: 4
Filing time: 11 Mar 2024, 10:12:03 UTC
Previous filing: 31 Oct 2023
Next filing: 18 Jun 2024
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CMPX	Stock Option (Right to Buy)	Award	$0	+40,000		$0.000000	40,000	08 Mar 2024	Common Stock	40,000	$1.96	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The options vest over 48 substantially equal monthly installments starting April 8, 2024.
F2	The Reporting Person is a member of Enavate Sciences, LP ("Enavate"). Pursuant to an agreement with Enavate, the Reporting Person has agreed to receive and hold for the benefit of Enavate any securities issued under any stock options or other awards granted to him for his services as a director on the Issuer's board of directors. As such, the Reporting Person disclaims beneficial ownership of, and all right, title and interest in, the reported securities.

Content

The options vest over 48 substantially equal monthly installments starting April 8, 2024.

The Reporting Person is a member of Enavate Sciences, LP ("Enavate"). Pursuant to an agreement with Enavate, the Reporting Person has agreed to receive and hold for the benefit of Enavate any securities issued under any stock options or other awards granted to him for his services as a director on the Issuer's board of directors. As such, the Reporting Person disclaims beneficial ownership of, and all right, title and interest in, the reported securities.